This topic contains a solution. Click here to go to the answer

Author Question: Patients not requiring continuous intravenous infusions may have a(n) A. piggyback. B. ... (Read 61 times)

newbem

  • Hero Member
  • *****
  • Posts: 579
Patients not requiring continuous intravenous infusions may have a(n)
 
  A. piggyback.
  B. intermittent infusion device.
  C. secondary line.
  D. primary line.

Question 2

Order: Heparin sodium 670 units IV q.12h. The label on the vial reads 1,000 units/mL. How many milliliters will you administer?
 
  1. 1.5 mL
  2. 0.67 mL
  3. 0.067
  4. 0.15



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Joc

  • Sr. Member
  • ****
  • Posts: 317
Answer to Question 1

B

Answer to Question 2

2
Rationale 1:




newbem

  • Member
  • Posts: 579
Reply 2 on: Jul 3, 2018
Great answer, keep it coming :)


FergA

  • Member
  • Posts: 352
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

Not getting enough sleep can greatly weaken the immune system. Lack of sleep makes you more likely to catch a cold, or more difficult to fight off an infection.

Did you know?

IgA antibodies protect body surfaces exposed to outside foreign substances. IgG antibodies are found in all body fluids. IgM antibodies are the first type of antibody made in response to an infection. IgE antibody levels are often high in people with allergies. IgD antibodies are found in tissues lining the abdomen and chest.

Did you know?

Cutaneous mucormycosis is a rare fungal infection that has been fatal in at least 29% of cases, and in as many as 83% of cases, depending on the patient's health prior to infection. It has occurred often after natural disasters such as tornados, and early treatment is essential.

Did you know?

Before a vaccine is licensed in the USA, the Food and Drug Administration (FDA) reviews it for safety and effectiveness. The CDC then reviews all studies again, as well as the American Academy of Pediatrics and the American Academy of Family Physicians. Every lot of vaccine is tested before administration to the public, and the FDA regularly inspects vaccine manufacturers' facilities.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library